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Abstract
Background: q-value is a widely used statistical method for estimating false discovery rate (FDR), which is a
conventional significance measure in the analysis of genome-wide expression data. q-value is a random variable and it
may underestimate FDR in practice. An underestimated FDR can lead to unexpected false discoveries in the follow-up
validation experiments. This issue has not been well addressed in literature, especially in the situation when the
permutation procedure is necessary for p-value calculation.
Results: We proposed a statistical method for the conservative adjustment of q-value. In practice, it is usually
necessary to calculate p-value by a permutation procedure. This was also considered in our adjustment method. We
used simulation data as well as experimental microarray or sequencing data to illustrate the usefulness of our method.
Conclusions: The conservativeness of our approach has been mathematically confirmed in this study. We have
demonstrated the importance of conservative adjustment of q-value, particularly in the situation that the proportion
of differentially expressed genes is small or the overall differential expression signal is weak.
Keywords: False discovery rate, q-value, Conservative adjustment

Background
Microarray and sequencing technologies have been widely
used in genome-wide expression experimental for biological and medical studies [1–5]. After screening a large
number of genes simultaneously, we expect to achieve
new biological discoveries. In these situations, an important statistical concept is multiple hypothesis testing, in
which many statistical tests are conducted at the same
time. Then, a detection of gene with relatively small
p-value may be actually a false discovery. Since the introduction of microarray technology, the concept of false
discovery rate (FDR) and its related statistical methods have been well developed [6, 7]. q-value is a statistical method for the estimation of FDRs [8]. It has
been widely used in the analysis of microarray and
sequencing data.
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Since q-value is an estimation method, it is possible that
it underestimates true FDRs. Then, an undesirable consequence is that many genes detected with low q-value cannot be validated in a follow-up experiment. Therefore, it
is important to avoid underestimations of FDRs. However,
there is a lack of statistical method to address this important issue. Furthermore, in many situations, q-values are
calculated based on p-values that are evaluated based
on a permutation procedure (due to unknown data distributions or non-traditional test statistics). Then, these
p-values are also estimated. This increases the complexity of FDR underestimations. It is necessary to adjust the
underestimation of FDRs in a comprehensive approach.
In this study, we proposed a statistical method for the
conservative adjustment of q-value, which is one of the
most frequently used procedure for estimating FDRs. We
first reviewed the concepts of multiple hypothesis testing, FDR and q-value. Then, we introduced a concept of
conservative adjustment. Based on the theory of rankbased quantiles, we described a non-parametric approach
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and we conducted simulation and application studies to
illustrate its usefulness.

and Tibshirani [8] proposed that the FDR for T = t could
be approximated by the proportion of false positives:
FDR(t) ≈ f (t)/s(t)

Methods

(1)

= mπ0 Pr(T ≥ t|H0 )/[ mPr(T ≥ t)] ,

Multiple hypothesis testing and false discovery rate

When a large number of variables are simultaneously
screened, it is usually a situation that a mixture of true
and false null hypotheses is presented. (There is a hypothesis to test for each variable but the underlying true/false
nature is unknown). Statistically, this is a situation of multiple hypothesis testing (MHT). An illustrative summary
is shown in Table 1. After certain statistical tests for m
total hypotheses, with a threshold for declaring significance, we have R hypotheses rejected (claimed positives).
If we know the underlying nature of each variable, then its
related hypothesis can be classified as either a true null or
a false null (termed gold standard). If this information is
provided, then we know the numbers U, V, W and S in
Table 1. U, V, W and S represent the numbers of true negatives, false positives, false negatives and true positives,
respectively. However, in practice, the gold standard information (or the underlying nature) is usually unknown.
Therefore, it is statistically interesting to evaluate U, V, W
or S (or their combinations).
The traditional family-wise error rate (FWER) provides
a strong control on V [9]. Since FWER is too conservative (for example, requiring extremely small p-value
threshold), it is usually difficult to claim statistical significance. The false discovery rate (FDR) has been proposed
to empirically evaluate the proportion of false positives
among the claimed positives: V /R [6]. The concept of
FDR and its related estimations have been widely used in
the analysis of genome-wide expression data collected by
microarray or RNA sequencing technologies. Particularly,
q-value [8] is one of the most widely used method for FDR
estimation.
q-Value

Storey and Tibshirani [8] proposed the q-value method
that is a statistical procedure for FDR evaluation. Suppose
T is the test statistic and genes with test scores greater
than or equal to t will be claimed significant. Let α be the
p-value at t, and let f (t) and s(t) be the expected numbers
of false positives and significant genes, respectively. Storey

where m is the total number of genes and π0 is the proportion of true null hypotheses (i.e. π0 = m0 /m in Table 1).
With a proper estimator π̂0 for π0 , they proposed the
q-value as a FDR estimator:
q(t) = mπ̂0 α/(#{T ≥ t}),
where (#{T ≥ t}) estimates mPr(T ≥ t).
Conservative adjustment of q-value

In practice, it can be difficult to obtain the theoretical pvalue of t. Therefore, a permutation based p-value α̂ has
been widely used to estimate α. Then, the permutation
version of q-value is
q(t) = mπ̂0 α̂/(#{T ≥ t}).
When the permutation method [10] is used to evaluate
p-values, it is possible to obtain underestimated results.
We have proposed a conservative adjustment of permutation p-values to address this issue [11].
Similarly, the above FDR can be underestimated since a
q-value is actually a combination of three estimates:
• π̂0 for π0 ,
• α̂ for α,
• (#{T ≥ t}) for mPr(T ≥ t).
From above, notice that mPr(T ≥ t) must still be empirically estimated even when α can be theoretically determined. To address the underestimation of FDR (from
q-value), our solution is to consider a conservative adjustment of q(t).
According to Eq. (1), the theoretical q-value for T = t
can be defined as:
q̃(t) = π0 α(t)/γ (t),
where α(t) = Pr(T ≥ t|H0 ) and γ (t) = Pr(T ≥ t).
We define the 100(1 − a)% conservative adjustment of
q(t) as an estimator q̂c (t) ∈[ 0, 1] such that:
Pr[ q̂c (t) ≥ q̃(t)] ≥ 1 − a.
Our solution for q̂c (t) is to find π̂0c , α̂c (t) and γ̂c (t) such
that:

Table 1 A summary in the situation of multiple hypothesis
testing
True null

False null

Total

Negative

U

W

m−R

Positive

V

S

R

Total

m0

m − m0

m

This table shows the numbers of true/false negatives/positives in the situation of
multiple hypothesis testing. The details are described in the Methods section

Pr(π̂0c ≥ π0 ) ≥ 1 − a0 ;
Pr[ α̂c (t) ≥ α(t)] ≥ 1 − a1 ;
Pr[ γ̂c (t) ≤ γ (t)] ≥ 1 − a2 .
If (1 − a0 )(1 − a1 )(1 − a2 ) ≥ 1 − a, then we claim that
π̂0c α̂c (t)/γ̂c (t) satisfies the requirement for q̂c (t), given
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π0 , α(t) > 0 and Pr[ γ̂c (t) > 0] = 1. The mathematical
proof is given as an Appendix.
Remark q̂c (t) is actually an upper confidence limit of
q̃(t). However, due to the difficulty in the accurate estimation of π0 (π0 is usually conservatively estimated), it
is difficult to calculate a lower confidence limit of q̃(t) in
practice.
Conservative estimation of π0

Due to the identifiability issue, π0 (the proportion of true
null hypotheses) is usually conservatively estimated in
practice [12]. Many statistical methods have been proposed for the estimation of π0 [13]. Among them, the
convest [14] is a well-recognized method that conservatively estimates π0 . (Instead of estimating the true π0 ,
it estimates a close upper bound of π0 . Therefore, the
estimation is conservative since the proportion of nondifferentially expressed genes is usually overestimated in a
differential expression analysis). According to our experience, it is reasonable to assume that
Pr(π̂0c ≥ π0 ) ≈ 1,
When π̂0c is the convest method (or other similar methods). Then, we discuss α̂c (t) and γ̂c (t), which are closely
related to some rank-based quantiles.
Conservative adjustment of rank-based quantiles

In a differential expression analysis, only q-values associated with observed test scores can be evaluated, and it
is difficult to accurately evaluate the q-values for unobserved test scores. Here are the mathematical details. With
a test statistic T, we can obtain m observed test scores
{T1 , T2 , . . . , Tm } for m variables (genes). An empirical
estimate of γ (t) = Pr(T ≥ t) is
γ̂ (t) =

m


δ(Ti ≥ t)/m,

i=1

where the indicator function δ(TRUE) = 1 and
δ(FALSE) = 0. If we sort these m test scores in an
increasing order: T(1) ≤ T(2) ≤ . . . ≤ T(m) , then we have
γ̂ (T(i) ) = (m − i + 1)/m,
which is a rank-based quantile estimator.
If the theoretical distribution of T is unknown, then we
need to use the permutation procedure [10] for evaluating
p-values. In the permutation procedure, we permute sample labels and recalculate test scores. Since the observed
test scores (scores calculated based the original data)
can also be considered as the results from a particular
permutation, they are generally included in the pool of
permuted test scores. Based on r permuted test scores:
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{T10 , T20 , . . . , Tr0 }, an empirical estimate of α(t) = Pr(T ≥
t|H0 ) is
α̂(t) =

r


δ(Ti0 ≥ t)/r.

i=1

If we sort these r permuted test scores in an increasing
0 ≤ T 0 ≤ . . . ≤ T 0 , then we have
order: T(1)
(2)
(r)
0
) = (r − i + 1)/r.
α̂(T(i)

Note that, if the observed test scores are not included
in the pool of permuted test scores, then the permutation
0 ) = (r − k + 1)/r, where
p-value of T = t will be α̂(T(k)
0
T(k) ≥ t is the closest order statistic to t. Therefore, the
permutation p-value of T = t can also be considered as a
rank-based quantile estimator.
Since γ̂ and α̂ are both random variables, it is possible for them to underestimate their target parameters.
The above discussion shows that, in practice, γ̂ and α̂
are actually both rank-based quantile estimators. Based
on the theory of order statistics [15], we have proposed
a conservative adjustment for this type of estimator [11].
Such an adjustment requires no parametric assumption
on the distribution of test statistic and the solution can
be expressed by a normalised incomplete beta function.
Therefore, based on this adjustment, we can otain α̂c (t)
and γ̂c (t) such that Pr[ α̂c (t) ≥ α(t)] ≥ 1 − a1 and
Pr[ γ̂c (t) ≤ γ (t)] ≥ 1 − a2 .

Results
A simulation study

To understand how likely the q-value method underestimates the true false discovery rate, we conducted a
simulation study. We choose the normal distributions for
simulating expression data and the Student’s t for differential expression. In this way, we could evaluate the true
false discovery rate theoretically.
Ten thousand genes were simulated for two sample
groups with sample size 5 for each group (10 for total
sample size). For non-differentially expressed genes, the
expression data were simulated from N(0, 1) for both
groups. Then, we considered four scenarios. For the
first simulation scenario, the proportion of differentially
expressed genes was 10%; the expression data for differentially expressed genes were simulated from N(0, 1) and
N(1, 1) for the first and the second sample groups, respectively ( = 1). For the second simulation scenario, the
proportion of differentially expressed genes was 10%; the
expression data for differentially expressed genes were
simulated from N(0, 1) and N(2, 1) for the first and the
second sample groups, respectively ( = 2). For the
third simulation scenario, the proportion of differentially
expressed genes was 20%; the expression data for differentially expressed genes were simulated from N(0, 1)
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and N(1, 1) for the first and the second sample groups,
respectively ( = 1). For the last simulation scenario,
the proportion of differentially expressed genes was 20%;
the expression data for differentially expressed genes were
simulated from N(0, 1) and N(2, 1) for the first and the
second sample groups, respectively ( = 2).
For all different scenarios, the Student’s t-test was used
for differential expression analysis. To evaluate p-values,
we performed all possible (126) permutations for each
simulated gene and pooled all 1,260,000 permuted test
scores together as the empirical null distribution. (In practice, the underlying data distributions are unknown and
the permutation procedure is widely used.) For each scenario, we conducted 100 repetitions to understand the
variations in the simulation results.
The simulation results are shown in Fig. 1. For each
scenario, the theoretical true FDRs is compared to their
related estimates (q-values). In summary, when the proportion of differentially expressed genes (1 − π0 ) becomes
smaller (from 20 to 10%), it is more likely to obtain underestimated FDRs; when the signal of differential expression () becomes weaker, it is more likely to obtain
underestimated FDRs. Figure 2 gives a scenario with a

An artificial illustration

A conservative adjustment of false discovery rate (FDR)
can be useful in practice, especially before the experimental validation of genes identified from a genome-wide
expression study. For example, based on a microarray or
RNA-seq study, one may want to validate a few genes with
q-value less than 10%. However, it may be surprising that
much less genes can be confirmed after the RT-PCR validation. (The validation result is beyond our expectation
based on 5% estimated FDR.) This hypothetical situation
would be an example of under-estimation of FDR.

b
0.500
0.005

Δ=1, π0=90%
0.1

c

0.2

0.5

1.0

Δ=2, π0=90%
0.005

d

0.020

0.100

0.500

Theoretical FDR

Δ=1, π0=80%
0.05

0.10

0.20

0.50

Theoretical FDR

1.00

0.001

0.005

0.005

0.050

q−Value

0.100

0.500

0.500

Theoretical FDR

0.020

q−Value

0.100
0.020

q−Value

0.050
0.001

0.005

q−Value

0.500

a

moderate proportion of differentially expressed genes (1−
π0 = 15%) and overall moderate differential expression
signals ( = 1.5). Each curve is a comparison between
the empirical FDRs (q-values) vs. theoretical FDRs (based
on one repetition of simulation). Below 0.05 theoretical
FDR, some curves can be observed under the diagonal
line, which indicate that these empirical FDRs (q-values)
are underestimated. Furthermore, among 100 repetitions,
there is a considerable portion of empirical FDRs underestimated (when the theoretical FDR below 0.05).

Δ=2, π0=80%
0.001

0.005

0.050

0.500

Theoretical FDR

Fig. 1 Simulation results for four scenarios. a Relatively weak differential expression and relatively small proportion of differential expression.
b Relatively strong differential expression but relatively small proportion of differential expression. c Relatively weak differential expression but
relatively large proportion of differential expression. d Relatively strong differential expression and relatively large proportion of differential
expression. The simulation details are described in the Results section

Lai BMC Bioinformatics 2017, 18(Suppl 3):69

0.100
0.005

0.020

q−Value

0.500

Page 159 of 175

Δ=1.5, π0=85%
0.01 0.02

0.05 0.10 0.20

0.50 1.00

Theoretical FDR
Fig. 2 Simulation results for a typical scenario. Moderate differential
expression and moderate proportion of differential expression. The
simulation details are described in the Results section

To demonstrate the above situation, we conducted a
simple simulation study. 10,000 genes were simulated for
two sample groups. The sample size was 5 for each group.
The proportion of differentially expressed genes was 10%.
The expression profiles of differentially expression genes
were simulated from N(0, 1) and N(1, 1) for the first and
the second sample groups, respectively. The expression
profiles of non-differentially expressed genes were simulated from N(0, 1) for both groups. The Student’s t-test
was used for differential expression analysis. To evaluate
p-values, we performed all possible (126) permutations for
each simulated gene and pooled all 1,260,000 permuted
test scores together as the empirical null distribution. (In
practice, the underlying data distributions are unknown
and the permutation procedure is widely used.) The convest method proposed by Langaas et al. [14] was used to
obtain an estimated π0 , which was used in the q-value
estimation procedure [8]. In this simulation it is feasible
to calculate the true FDR theoretically. Figure 3 shows
that the low values of true FDR can be seriously underevaluated by q-value. Then, we considered a conservative
0 (since π0 is usually
adjustment. We set a0 = √
√ conservatively estimated), a1 = 1− 0.95 and a2 = 1− 0.95 (then
a = 0.05). Figure 3 shows the conservatively adjusted
q-values.
Three applications

We applied our method to two genome-wide expression
data sets. The first one was a microarray data set and it
was collected for a diabetes study. It is well-known that
differential expression signals are usually weak in diabetes
studies. When the sample size is not relatively large, it

is usually difficult to detect true differentially expressed
genes. (Due to the inflated false positive rates from the
multiple hypothesis testing for a large number of genes,
genes with seemingly small FDRs are likely noise genes).
It is interesting to understand the adjustment effects from
our method for this scenario. The second one was a RNA
sequencing (RNA-seq) data set and it was collected for
a prostate cancer study. It is also well-known that differential expression signals are usually strong in cancer
studies. Genome-wide expression data for different types
of cancer have been increasingly collected in The Cancer Genome Atlas project [3]. The current sample sizes in
many TCGA cancer studies are relatively large. Then, it is
also interesting to understand the adjustment effects from
our method for such as scenario.
In practice, it is not feasible to calculate the theoretical true FDRs. The curve of estimated FDR vs. number of
identified genes is widely used to for a summary of differential expression analysis. (In this curve, the y-value is
a specific FDR and the x-value is the related number of
genes with the specific FDR). Our application results can
also be summarized in term of this type of curve.
For the first microarray genome-wide expression data
set for a type 2 diabetes study [16], there were 17 normal subjects and 18 diabetic subjects. After the procedure
of gene filtering [16], there are 10,983 genes. Based on
1,000 permutations and the related Student’s t-test calculations, there were 10,983,000 permuted test scores as our
empirical null distribution for p-value evaluations. (Since
it is difficult to enumerate all possible permutations, we
performed 1,000 of them). We set a0 = 0 (since π0 is
already conservatively
estimated by√the convest method
√
[14]), a1 = 1 − 0.95 and a2 = 1 − 0.95 (then a = 0.05).
Figure 4a shows that the q-values (estimated FDRs) can
only be as low as slightly less than 0.2. There were only
several genes with q-values around 0.2. However, after our
conservative adjustment, Fig. 4a shows that all the conservatively adjusted q-values are greater than 0.8. This
comparison implies that most genes were very likely noise
genes and the detections of differentially expressed genes
by low q-values could be very unreliable. The only gene
with q-value less than 0.2 is a mRNA for CD20-like precursor. However, no literature was found to support its
association with diabetes diseases.
For the second RNA-seq genome-wide expression data
set for a prostate cancer study [3], there were 52 normal
subjects and 445 tumor subjects (at the time of data download for this analysis). There are 20,531 genes. Since the
sample size was large and the RNA-seq expression profiles were count-type data, we used the non-parametric
Wilcoxon rank sum test with its theoretical p-values calculation. Therefore, there was no need for an adjustment
of p-values (i.e. a1 = 0). Then, we set a0 = 0 (since π0 is
already conservatively estimated by the convest method

1.00
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0.20
0.10

q−Value

0.50

Δ=1, π0=90%

0.05

Original
Adjusted
0.1

0.2

0.5

1.0

Theoretical FDR
Fig. 3 A simulation example for an artificial illustration. The theoretical true false discovery rate (FDR) is compared to the related estimate by q-value.
This is a scenario with relatively weak differential expression and relatively small proportion of differential expression. Dark circles represent original
(unadjusted) q-values and dark triangles represent conservatively adjusted q-values. The simulation details are described in the Results section

[14]) and a2 = 1 − 0.95 (then a = 0.05). Figure 4b shows
that the q-values (estimated FDRs) can be extremely low
and lots of genes can be detected. After our conservative
adjustment, Fig. 4b shows that the curve of adjusted qvalues almost overlaps with the curve of original q-values.
This comparison implies that many genes were truly differentially expressed genes and the detection of these
genes by low q-values could be highly confident. After
checking literature for top ranked genes, many of them
have been studied to be either directly or indirectly related
to prostate cancer or general cancer diseases (details not
shown).
For the third microarray genome-wide expression data
set for a pancreatic-islet study [17], there were 7 normal patients and 5 type 2 diabetic patients. There are
44,928 genes and ESTs. Based on all possible permutations and the related Student’s t-test calculations. We
set a0 = 0 (since π0 is already conservatively√estimated by the convest method [14]), a1 = 1 − 0.95

√
and a2 = 1 − 0.95 (then a = 0.05). Figure 4c
shows that the q-values (estimated FDRs) can only be
as low as approximately 0.4 (about 20 genes). However,
after our conservative adjustment, Fig. 4c shows that all
the conservatively adjusted q-values are greater than 0.5.
This comparison implies that more top ranked genes
were likely noise genes. The only two genes with qvalue less than 0.4 are mRNAs for ARNT and APCDD1.
Although ARNT has been widely studied for its association with diabetes diseases, no literature was found to
support the association between APCDD1 and diabetes
diseases.

Discussion
For our method, there are three components that can be
adjusted separately. The first component is on π0 estimation. Since the estimators for π0 are usually conservative
(especially for the convest method [14]), we do not suggest any adjustment for this component according to our
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Fig. 4 Three applications to experimental genome-wide expression data. a A microarray data set collected for a type 2 diabetes study. b A RNA
sequencing (RNA-seq) data set collected for a prostate cancer study in The Cancer Genome Atlas (TCGA) project. c A microarray data set collected
for a pancreatic islet study. The curves represent q-value (as estimated FDR) vs. its related number of identified genes. In each application, dark solid
curve represents original (unadjusted) q-values and dark dashed curve represents conservatively adjusted q-values
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experience. The last component is on the number of identified genes. It can be adjusted based on the theory of
order statistic. The second component is on p-values.
When theoretical p-value can be obtained, it is not necessary to adjust this component. For permutation p-values,
an adjustment can be also performed based on the theory
of order statistic. Notice that the number of permutations
is also important. In practice, we need to determine it
before data analysis. When the sample size is relatively
small, we can enumerate all possible permutations. When
the sample size is relatively large, we can set the number of permutations as large as possible according to the
computing power.
A clear advantage of our approach is that there are rigorous mathematical theories to support it. Furthermore,
no distribution assumptions are required for our conservative adjustment. However, the adjustment may be
over-conservative. If we could further improve the control of upper/lower bounds (as shown in our mathematical
proof ), then less conservative adjustment of q-value could
be achieved. Furthermore, an independence assumption
is required. It is well-known that genes work with each
other during molecular and cellular processes. It would
be an interesting future research topic to address the
dependence among genes. Therefore, it will be our future
research topics to investigate possible better upper/lower
bounds for the conservative adjustment of q-value, as
well as the impact of dependence on the conservative
adjustment of q-value.

Conclusions
In this study, we proposed a statistical method for the
conservative adjustment of q-value, which is widely used
to estimate false discovery rate (FDR) in practice. We
provided a mathematical proof to confirm the conservativeness of our approach. We conducted simulation studies to understand how likely the q-value method would
underestimate FDRs. From our simulation results, both
the proportion of differentially expressed genes and the
overall differential expression signal were two important
factors. When both of them were relatively small/weak,
it was likely to identify genes with underestimated FDRs.
Our first application was based on a microarray diabetes
study data set with relatively small sample size (and weak
differential expression signals). Our third application was
based on a microarray pancreatic islet study data set with
relatively small sample size (and also weak differential
expression signals). The results were consistent with the
conclusion from our simulation studies. Our second application was based on a RNA-seq prostate cancer study data
set with relatively large sample size (and strong differential
expression signals). According to the results, the conservatively adjusted q-values were close to the originally
unadjusted q-values.
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Appendix 1
Mathematical Proof:


π̂0c α̂c (t)
π0 α(t)
Pr
≥
γ̂c (t)
γ (t)



π0 α(t) 
π̂0c α̂c (t)
π̂0c ≥ π0 Pr(π̂0c ≥ π0 )
≥
= Pr
γ̂ (t)
γ (t) 


 c
π̂0c α̂c (t)
π0 α(t) 
+Pr
<
π
π̂
≥
0c
0 Pr(π̂0c < π0 )
γ̂c (t)
γ (t) 



π̂0c α̂c (t)
π0 α(t) 
≥ Pr
π̂0c ≥ π0 Pr(π̂0c ≥ π0 )
≥
γ̂ (t)
γ (t) 

 c

π̂0c α̂c (t)
α(t) 
≥ Pr
π̂
≥
≥
π
0c
0 (1 − a0 )
π0 γ̂c (t)
γ (t) 



π̂0c α̂c (t)
α(t)  π̂0c
= Pr
≥
1
(1 − a0 )
≥
π0 γ̂c (t)
γ (t)  π0


α(t)
α̂c (t)
≥ (1 − a0 )Pr
≥
Remark
γ̂c (t)
γ (t)

 

α̂c (t) α(t)
α̂
≥
= (1−a0 ) Pr
(t)
≥
α(t)
Pr[ α̂c (t) ≥ α(t)]
c
γ̂c (t) γ (t)




α(t) 
α̂c (t)
α̂
≥
(t)
<
α(t)
Pr[
α̂
(t)
<
α(t)]
+Pr
c
c
γ̂c (t)
γ (t) 



α̂c (t) α(t) 
α̂c (t) ≥ α(t) Pr[ α̂c (t) ≥ α(t)]
≥
≥ (1 − a0 )Pr
γ̂c (t) γ (t) 



1  α̂c (t)
α̂c (t) 1
= (1 − a0 )(1 − a1 )Pr
≥
≥1
α(t) γ̂c (t)
γ (t)  α(t)


1
1
≥ (1 − a0 )(1 − a1 )Pr
≥
Remark
γ̂c (t)
γ (t)
= (1 − a0 )(1 − a1 )Pr[ γ̂c (t) ≤ γ (t)]
= (1 − a0 )(1 − a1 )(1 − a2 )
Remark For any random variable X, Y and a constant c,
Pr(XY ≥ c|X ≥ 1) ≥ Pr(Y ≥ c) since Y ≥ c =⇒ XY ≥ c
given X ≥ 1 ({Y ≥ c} is a subset of {XY ≥ c} when X ≥ 1).

Appendix 2
R-functions for calculating conservatively adjusted qvalues.
p.conservative.right <- function(p, n,
alpha=0.05){
return( qbeta(alpha, n*p+1, n-n*p) )
}
p.conservative.left <- function(p, n,
alpha=0.05){
return( qbeta(1-alpha, n*p+1, n-n*p) )
}
pi0est*(1-p.conservative.right(1-pvals, r,
1-sqrt(0.95)))/
(1-p.conservative.left(1-rank(pvals)/m, m,
1-sqrt(0.95)))

Lai BMC Bioinformatics 2017, 18(Suppl 3):69

Notice that pi0est is a conservative estimate of π0 ; pvals
is a list of permutation p-values based on r permutations;
m is the number of permutation p-values (also the number
of genes).
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